
Opinion|Videos|September 4, 2024
PSMA PET vs. Gallium-Based PET: Navigating NCCN Guidelines in Prostate Cancer Imaging
Author(s)Jaideep S. Sohi, MD, Jeremie Calais, MD
Jaideep Sohi, MD, and Jeremie Calais, MD, examine the comparative merits of PSMA PET and Gallium-Based PET while exploring the application of NCCN Guidelines in prostate cancer imaging protocols.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the NCCN Guidelines' recommendations for gallium-based versus non-gallium-based PET agents in prostate cancer imaging, and how does PSMA PET imaging impact prostate cancer care in your view?
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
From Adoption to Governance in Radiology: Navigating the Next Wave of Imaging AI
2
Observations and Reflections from the 2026 SNMMI Conference: An Interview with Jeremie Calais, MD, PhD
3
Study Shows 45 Percent Increase in Emergency Department Neuroimaging Over the Last Decade
4
FDA Clears Emerging AI Segmentation Module for Brain MRI
5












